This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Trials in Progress
Trials in Progress
ECLIPSE Trial
Oral EPI-7386
SPLASH Trial
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO 2023
AUA 2023
ASCO GU 2023
EAU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2017
AUA 2017
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis & Penile Cancers
BPH
GU Reconstruction
Infections & Inflammation
Sexual Function
Stone Disease - Endourology & Technology
Urinary Incontinence
Press Releases
AUA 2017 Kidney Cancer
Viewing 1-20 of 36 articles
AUA 2018: Inferior Vena Cava Level II Tumor Thrombectomy: Which is Best: Robot or Open?
AUA 2017: Best Abstract – Are the current follow-up guidelines after treatment for organ confined renal cancer sufficient?
AUA 2017: Best Abstract – Liquid biopsy for renal cell carcinoma
AUA 2017: A molecular scoring algorithm to predict survival in metastatic renal cell carcinoma
AUA 2017: Thromboembolic events during treatment for renal cell carcinoma: must we prevent?
AUA 2017: Can looks deceive? Not all clinically “cystic” renal masses harbor indolent biology
AUA 2017: Differential gene expression in patients with indolent versus aggressive chromophobe renal cell carcinoma: An analysis of the cancer genome atlas database
AUA 2017: A Multi-Institutional Propensity Score Matched Comparison of Transperitoneal vs. Retroperitoneal Robotic Partial Nephrectomy for Posterior Clinical T1 Renal Masses
AUA 2017: Impact of Renal Vein Invasion on the Outcome in Patient with Renal Cell Carcinoma and Caval Thrombus
AUA 2017: Renal Mass Biopsy is Associated with increased Incidence of Pathological Upstaging to Perinephric Fat Invasion in Patient with Clinically Localized Renal Cell Carcinoma.
AUA 2017: Surgical Approach Does Not Impact Positive Margin Rate in Partial Nephrectomy for Large Renal Masses
AUA 2017: Role of Biopsy in the Management of Small Renal Masses
AUA 2017: Best Kidney Cancer Papers from the Past Year
AUA 2017: First Results of A-Predict: A Phase II Study of Axitinib in Patients with Metastatic Renal Cell Cancer (RCC) Unsuitable for Nephrectomy
AUA 2017: Modified 5-item frailty index is associated with increased healthcare resource utilization following elective minimally invasive radical nephrectomy
AUA 2017: Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥ 4 cm)? A propensity score matched study
AUA 2017: Society of Urologic Oncology: Cystic renal masses – Radiographic assessment and management
AUA 2017: The Role of Neoadjuvant and Adjuvant Systemic Therapy in Renal Cell Carcinoma
AUA 2017: The Re-emergence of Immunotherapy in Renal Cell Carcinoma and Novel Clinical Trials
AUA 2017: Identifying barriers to the adoption of percutaneous renal tumour biopsy in the management of small renal masses
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free